ClinicalTrials.gg
CompletedNCT03654807Updated Nov 2, 2026Results posted

The Effect of Walking on Frailty

An interventional study of High Intensity Walking and Casual Speed Walking in Frailty, sponsored by Northwestern University. Completed at 1 site in United States. Open to participants aged 60 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-02.

Sponsored by Northwestern University · Not applicable, Interventional, and Treatment

How we know

Updated Nov 2, 2026Results postedStudy documents posted+2 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
165
Allocation
Randomized
Ages
60 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 185 studies in Frailty with a site in United States — 48 open to participants now, 61 under way, 1 of them phase 3. Frailty · United States.

Enrollment
14th of 142
165 · median 42
Started
2018
with 18 others
No phase
93 of 185
27 open now
Registered
64th of 185
by date
Lead sponsor
5 of 185
Northwestern University

Among the 185 studies in Frailty with a site in United States, this one is the 14th largest by enrollment of the 142 interventional ones that give a count, is one of 19 that started in 2018, is one of 93 with no phase, and was the 64th registered.

Frailty

1,291 studies on the registry are indexed under Frailty; 454 are open to participants now.

Browse Frailty studies →

Open to participants now

48 of the 185 studies in Frailty with a site in United States are open now. Recruiting first, the newest first:

43 more — sign in →

All 48 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 299 Frailty studies recruiting now, 235 (79%) set no upper age limit and 10 (3%) stop at 75 or younger; 7 take children under 18; 66 take healthy volunteers.

This study: 60 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 185 studies in Frailty with a site in United States, or all of them as a file.
02

Study summary

The purpose of this study is to test the effect of walking intensity on both frailty category (i.e., frail, pre-frail, and nonfrail) and frailty score as a continuous outcome on the SHARE-FI (frailty instrument). As well as test the effect of walking intensity on mobility, physical function, balance, and total Physical Activity.

Read the detailed description

Frailty impacts up to 60% of older adults and is a leading cause of dependency among older adults. Frail older adults experience physical problems such as balance difficulties, weakness, decreased endurance, and reduced walking speed that increase risk for falls, hospitalizations, institutionalization, and death. Physical activity has multi-system health benefits and is the most recommended frailty management intervention, but guidelines regarding the specific intensity of physical activity remain unclear. High intensity physical activity is an established and safe therapeutic approach in other populations, but it is unclear as to the extent to which high intensity activity can reduce or reverse frailty. This cluster-randomized study will compare a high intensity walking (HIW) intervention to a self-selected, casual speed walking (CSW) intervention implemented within retirement communities for pre-frail and frail older adults. Investigators will randomize 10 retirement communities with 20 participants at each site (200 total participants) to either a 4-month HIW or CSW intervention. All participants will receive 48, individually supervised overground walking sessions occurring within their retirement community. At the beginning and end of the study, investigators will measure participants' frailty, mobility, physical functioning, balance, and total physical activity measured via an ActivPal accelerometer worn for a 1-week observation period to compare which treatment strategy, HIW or CSW, worked better to reduce frailty (aim #1). Investigators will use the SHARE-Frailty Instrument to evaluate frailty as both a categorical (e.g. non-frail, pre-frail, or frail) and a continuous outcome. This approach will allow investigators to determine how participants move between frailty categories as well as within frailty categories in response to intervention. In aim #2, investigators will determine the effect of walking intensity on mobility, physical functioning, balance, and total physical activity. Investigators hypothesize that HIW participants will show decreased frailty and improved mobility, physical functioning, balance, and physical activity at 4 months. Currently, the optimal physical activity guidelines for older adults with frailty are uncertain. Results from this study will provide important knowledge to inform activity guidelines for older adults with frailty and information on a transformative approach to reducing frailty, improving function, and increasing physical activity among a growing segment of the older adults population.

03

Conditions studied

  • Frailty

Browse trials for

04

Who can participate

Ages eligible
60 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

    • > 60 years of age with pre-frailty or frailty as determined on the SHARE-FI.

      • Able to ambulate at least 10 feet with moderate assistance (\<50% physical assistance) or less. Participants will be able to use their assistive device (e.g. cane or walker) during sessions.
      • Resident of one of the 10 enrolled retirement community locations. Individuals must be > 60 years of age to move into the retirement communities by virtue of the individual community policies.
      • Provision of and clearance for participation as determined by the Exercise and Screening for You (EASY).

Exclusion criteria

Exclusion Criteria:

    • Uncontrolled cardiovascular, metabolic, renal, or respiratory disease that limits exercise participation (e.g., previous heart attack within 3 months of enrollment or uncontrolled diabetes)

      • Resting blood pressure > 180/110 mmHg.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
165 participants (actual)

Study arms

  • Experimental
    High Intensity Walking

    HIW (70-80% HRmax)

    Behavioral: High Intensity Walking

  • Experimental
    Casual Speed Walking

    Self selected pace

    Behavioral: Casual Speed Walking

Interventions

  • BehavioralHigh Intensity Walking

    70-80% HRmax

  • BehavioralCasual Speed Walking

    Self selected pace

06

What researchers measure

Primary outcomes

  1. Survey of Health, Ageing, and Retirement in Europe-Frailty Instrument (SHARE-FI)

    Survey of Health Among Retired Europeans - Frailty Index (SHARE-FI) which assesses fatigue, appetite, weakness, walking difficulties, and low physical activity. There is not a max and min score; Higher scores indicate greater severity of frailty. Classification for Women: Non-frail: ≤0.315 Pre-frail: 0.316-2.130 Frail: ≥2.131 Classification for Men" Non-frail: ≤1.210 Pre-frail: 1.211-3.005 Frail: ≥3.006

    Time frame: Baseline and four months

Secondary outcomes

  1. Improved Mobility as Measured by Gait Speed

    Gait speed was measured independently as a continuous measure in meters per second (m/s). Participants completed two trials over 10 meters at both self-selected usual speed ("walk at your normal comfortable pace") and fastest-possible speed ("as fast as you safely can"), and the two trials were averaged for analysis.

    Time frame: Baseline and four months

  2. Improved Physical Function on the Short Physical Performance Battery

    The Short Physical Performance Battery is a scale to assess overall functional status and physical performance Min score = 0 Max score = 12 Higher scores = better physical function

    Time frame: Baseline and four months

  3. Improved Balance as Measured by the Berg Balance Scale

    The Berg Balance Scale is a valid and reliable 14 item tool to evaluate static and dynamic balance among older adults. Minimum Score: 0 to Maximum Score: 56 Score of \< 45 indicates individuals may be at greater risk of falling

    Time frame: Baseline and four months

  4. Total Daily Physical Activity

    ActivPal Activity Monitors worn for a one week ambulatory monitoring period, counting number of steps

    Time frame: Baseline and Four Months

  5. Time Up and Go

    Measures the time the participant takes to rise from a chair, walk 10 feet, turn around, walk back to the chair, and sit down

    Time frame: Baseline and Four Months

  6. 6 Minute Walk Test

    Distance walked in 6 minutes in meters

    Time frame: Baseline and Four Months

  7. Improved Balance as Measured by the Falls Efficacy

    Falls Efficacy Scale as this is a widely-used measure among older adults that evaluates the fear of falling and balance confidence, 10-item questionnaire with scores ranging from minimum score 0 to maximum score 100. A total score of greater than 70 indicates that the person has a fear of falling

    Time frame: Baseline and Four Months

07

Results

Posted Nov 2, 2026
Limitations and caveats
Although enrollment mirrored the demographics of senior living residents, 75% of our participants were white. Thus, the generalizability of our findings to other ethnic groups and diverse populations needs to be established in future studies. We acknowledge a large drop-out rate from enrollment to analysis (36%). Attrition is a widespread challenge in exercise programs and an estimated 50% of participants drop

Participant flow

Participant flow — Overall Study
MilestoneHigh Intensity WalkingCasual Speed Walking
Started8184
Completed4758
Not completed3426

Outcome measures

PrimarySurvey of Health, Ageing, and Retirement in Europe-Frailty Instrument (SHARE-FI)

Survey of Health Among Retired Europeans - Frailty Index (SHARE-FI) which assesses fatigue, appetite, weakness, walking difficulties, and low physical activity. There is not a max and min score; Higher scores indicate greater severity of frailty. Classification for Women: Non-frail: ≤0.315 Pre-frail: 0.316-2.130 Frail: ≥2.131 Classification for Men" Non-frail: ≤1.210 Pre-frail: 1.211-3.005 Frail: ≥3.006

Time frame:
Baseline and four months
Reported as:
Mean · score on a scale
Survey of Health, Ageing, and Retirement in Europe-Frailty Instrument (SHARE-FI)
score on a scaleHigh Intensity WalkingCasual Speed Walking
Baseline2.10 ± 1.102.35 ± 1.20
Four months0.61 ± 1.291.20 ± 1.47
SecondaryImproved Mobility as Measured by Gait Speed

Gait speed was measured independently as a continuous measure in meters per second (m/s). Participants completed two trials over 10 meters at both self-selected usual speed ("walk at your normal comfortable pace") and fastest-possible speed ("as fast as you safely can"), and the two trials were averaged for analysis.

Time frame:
Baseline and four months
Reported as:
Mean · m/s
Improved Mobility as Measured by Gait Speed
m/sHigh Intensity WalkingCasual Speed Walking
Baseline0.80 ± 0.230.81 ± 0.21
Four months0.89 ± 0.230.82 ± 0.20
SecondaryImproved Physical Function on the Short Physical Performance Battery

The Short Physical Performance Battery is a scale to assess overall functional status and physical performance Min score = 0 Max score = 12 Higher scores = better physical function

Time frame:
Baseline and four months
Reported as:
Mean · score on a scale
Improved Physical Function on the Short Physical Performance Battery
score on a scaleHigh Intensity WalkingCasual Speed Walking
Baseline6.74 ± 2.666.66 ± 2.69
Four months7.74 ± 2.827.41 ± 2.63
SecondaryImproved Balance as Measured by the Berg Balance Scale

The Berg Balance Scale is a valid and reliable 14 item tool to evaluate static and dynamic balance among older adults. Minimum Score: 0 to Maximum Score: 56 Score of \< 45 indicates individuals may be at greater risk of falling

Time frame:
Baseline and four months
Reported as:
Mean · score on a scale
Improved Balance as Measured by the Berg Balance Scale
score on a scaleHigh Intensity WalkingCasual Speed Walking
Baseline42.00 (34.00 to 49.50)42.00 (37.00 to 48.00)
Four months46.00 (40.50 to 51.00)47.50 (43.00 to 51.00)
SecondaryTotal Daily Physical Activity

ActivPal Activity Monitors worn for a one week ambulatory monitoring period, counting number of steps

Time frame:
Baseline and Four Months
Reported as:
Mean · steps/day
Total Daily Physical Activity
steps/dayHigh Intensity WalkingCasual Speed Walking
Baseline3699 ± 18103819 ± 2402
Four months4195 ± 21083330 ± 1811
SecondaryTime Up and Go

Measures the time the participant takes to rise from a chair, walk 10 feet, turn around, walk back to the chair, and sit down

Time frame:
Baseline and Four Months
Reported as:
Mean · seconds
Time Up and Go
secondsHigh Intensity WalkingCasual Speed Walking
Baseline16.56 (12.88 to 19.12)16.41 (13.17 to 20.09)
Four months13.85 (11.60 to 17.09)14.67 (12.85 to 18.55)
Secondary6 Minute Walk Test

Distance walked in 6 minutes in meters

Time frame:
Baseline and Four Months
Reported as:
Mean · m
6 Minute Walk Test
mHigh Intensity WalkingCasual Speed Walking
Baseline262.14 ± 95.12252.28 ± 82.97
Four months317.48 ± 100.34264.07 ± 97.40
SecondaryImproved Balance as Measured by the Falls Efficacy

Falls Efficacy Scale as this is a widely-used measure among older adults that evaluates the fear of falling and balance confidence, 10-item questionnaire with scores ranging from minimum score 0 to maximum score 100. A total score of greater than 70 indicates that the person has a fear of falling

Time frame:
Baseline and Four Months
Reported as:
Mean · score on a scale
Improved Balance as Measured by the Falls Efficacy
score on a scaleHigh Intensity WalkingCasual Speed Walking
Baseline18.57 ± 14.1318.48 ± 13.07
Four months17.68 ± 14.8215.88 ± 7.99

Adverse events

Collected over Adverse event data were collected over the course of the 4 month intervention that each participant was enrolled in the study.. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
High Intensity Walking0/81 (0%)4/81 (4.9%)7/81 (8.6%)
Casual Speed Walking0/84 (0%)9/84 (10.7%)2/84 (2.4%)
Most frequent serious events
Most frequent serious events
EventHigh Intensity WalkingCasual Speed Walking
Muscle sorenessMusculoskeletal and connective tissue disorders3/819/84
FallMusculoskeletal and connective tissue disorders1/810/84
Most frequent other events
Most frequent other events
EventHigh Intensity WalkingCasual Speed Walking
muscle sorenessMusculoskeletal and connective tissue disorders7/812/84

Baseline characteristics

Age, Continuous
Age, Continuous(years)High Intensity WalkingCasual Speed WalkingTotal
Mean79.2 ± 8.479.3 ± 7.879.2 ± 8.0
Sex: Female, Male
Sex: Female, Male(Participants)High Intensity WalkingCasual Speed WalkingTotal
Female424183
Male51722
Race (NIH/OMB)
Race (NIH/OMB)(Participants)High Intensity WalkingCasual Speed WalkingTotal
American Indian or Alaska Native000
Asian112
Native Hawaiian or Other Pacific Islander000
Black or African American91322
White364379
More than one race000
Unknown or Not Reported112
Frail on the Survey of Health Among Retired Europeans - Frailty Index (SHARE-FI)
Frail on the Survey of Health Among Retired Europeans - Frailty Index (SHARE-FI)(Participants)High Intensity WalkingCasual Speed WalkingTotal
Count of participants273562
08

Study locations

1 site
  • Northwestern Univiersity Department of Physical Therapy and Human Movement Sciences
    Chicago, Illinois 60611, United States
09

References and documents

Publications

  • Danilovich M, Rubin DS, Conroy DE, Diaz L, Cheung Y, Corcos D, Bonner LB. A high intensity vs. casual speed walking intervention to reverse frailty among older adults: a cluster randomized controlled trial. PLoS One. 2026 Sep 30;21(9):e0357605. doi: 10.1371/journal.pone.0357605. eCollection 2026. PubMed 42814673 ↗
  • Davila VS, Conroy DE, Danilovich MK. Factors That Influence Walking Intervention Adherence for Older Adults Living in Retirement Communities. J Aging Phys Act. 2022 Feb 1;30(1):65-72. doi: 10.1123/japa.2020-0279. Epub 2021 Aug 12. PubMed 34384049 ↗

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

10

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Nov 2018 to primary completion in Jan 2023, 50 months.

Results were first posted in Nov 2026, 3 years 9 months after primary completion.

Of 514 non-industry interventional studies with no phase under Frailty, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 39. This study's 50 months is above that.

Counting every sponsor, half of 519 studies reached it within 22 months; a quarter within 10 and three quarters within 39.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 21, 2018
First posted
Aug 31, 2018
StartActual
Nov 26, 2018
Primary completionActual
Jan 31, 2023
CompletionActual
May 31, 2024
Results first posted
Nov 2, 2026
Last update
Nov 2, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Results
Results posted
posted Nov 2, 2026
Enrollment
156→165
Nov 2, 2026
Primary outcomes
1 edited
What changed in the outcomes
  • EditedChange in frailty as measured by the Survey of Health, Ageing, and Retirement in Europe-Frailty Instrument (SHARE-FI)Time frame: Baseline and four months
Nov 2, 2026
Documents
Publications
1 publication citing this study linked from PubMed, e.g. PubMed 42814673 ↗
Nov 2, 2026
Secondary outcomes
7 edited
What changed in the outcomes
  • EditedImproved mobilityMobility as measuredMeasured by gait speedGait SpeedTime frame: Baseline and four months
  • EditedImproved physical functionPhysical Function on the Short Physical Performance BatteryTime frame: Baseline and four months
  • EditedImproved balanceBalance as measuredMeasured by the Berg Balance ScaleTime frame: Baseline and four months
  • EditedTotal daily physical activityDaily Physical ActivityTime frame: Baseline and Four Months
  • EditedImproved mobility as measured by Time Up and GoTime frame: Baseline and Four Months
  • EditedImproved mobility as measured by 6 Minute Walk TestTime frame: Baseline and Four Months
  • EditedImproved balanceBalance as measuredMeasured by the Falls EfficacyTime frame: Baseline and Four Months
Nov 2, 2026
Show all 1 update
  1. Nov 2, 2026
    Results posted
    Publications 1 publication citing this study linked from PubMed, e.g. PubMed 42814673 ↗
    Enrollment 156→165
    Primary outcomes 1 edited
    What changed in the outcomes
    • EditedChange in frailty as measured by the Survey of Health, Ageing, and Retirement in Europe-Frailty Instrument (SHARE-FI)Time frame: Baseline and four months
    Secondary outcomes 7 edited
    What changed in the outcomes
    • EditedImproved mobilityMobility as measuredMeasured by gait speedGait SpeedTime frame: Baseline and four months
    • EditedImproved physical functionPhysical Function on the Short Physical Performance BatteryTime frame: Baseline and four months
    • EditedImproved balanceBalance as measuredMeasured by the Berg Balance ScaleTime frame: Baseline and four months
    • EditedTotal daily physical activityDaily Physical ActivityTime frame: Baseline and Four Months
    • EditedImproved mobility as measured by Time Up and GoTime frame: Baseline and Four Months
    • EditedImproved mobility as measured by 6 Minute Walk TestTime frame: Baseline and Four Months
    • EditedImproved balanceBalance as measuredMeasured by the Falls EfficacyTime frame: Baseline and Four Months
    + 4 other changes: registry notes, index terms, verification date and responsible party

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

11

Registry details

Key details

Study ID
NCT03654807
Responsible party
Sponsor
First posted
Aug 31, 2018
Start date
Nov 26, 2018
Primary completion
Jan 31, 2023
Completion
May 31, 2024
Results posted
Nov 2, 2026
Last update
Nov 2, 2026

Study contacts

Margaret Danilovich, PhD
principal investigator · Northwestern University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion